The authors sought to identify the incidence, risk factors, and mortality impact of acute kidney injury (AKI) after general surgery using a large and representative national clinical data set.
The 2005-2006 American College of Surgeons-National Surgical Quality Improvement Program participant use data file is a compilation of outcome data from general surgery procedures performed in 121 US medical centers. The primary outcome was AKI within 30 days, defined as an increase in serum creatinine of at least 2 mg/dl or acute renal failure necessitating dialysis. A variety of patient comorbidities and operative characteristics were evaluated as possible predictors of AKI. A logistic regression full model fit was used to create an AKI model and risk index. Thirty-day mortality among patients with and without AKI was compared.
Of 152,244 operations reviewed, 75,952 met the inclusion criteria, and 762 (1.0%) were complicated by AKI. The authors identified 11 independent preoperative predictors: age 56 yr or older, male sex, emergency surgery, intraperitoneal surgery, diabetes mellitus necessitating oral therapy, diabetes mellitus necessitating insulin therapy, active congestive heart failure, ascites, hypertension, mild preoperative renal insufficiency, and moderate preoperative renal insufficiency. The c statistic for a simplified risk index was 0.80 in the derivation and validation cohorts. Class V patients (six or more risk factors) had a 9% incidence of AKI. Overall, patients experiencing AKI had an eightfold increase in 30-day mortality.
Approximately 1% of general surgery cases are complicated by AKI. The authors have developed a robust risk index based on easily identified preoperative comorbidities and patient characteristics.
ACUTE kidney injury (AKI) after cardiac and vascular surgery has been well studied but remains a prevalent, devastating, and costly complication.1–5Depending on the definition of AKI, it affects from 2% to 25% of cardiovascular surgery patients and increases the mortality and costs associated with these procedures by two to five times.1,3,6Although more than 6 million general surgery procedures are performed each year in the United States,7AKI in this group of patients has been largely unstudied.4In a study of 15,000 patients without significant preexisting kidney dysfunction, Kheterpal et al. 8recently demonstrated that approximately 1% of major noncardiac surgery procedures were complicated by AKI, defined as a significant reduction in calculated creatinine clearance to less than 50 ml/min.
The American College of Surgeons–National Surgical Quality Improvement Program (ACS–NSQIP) data set offers a unique opportunity to study perioperative morbidity and mortality in a broadly representative, national sample of patients. At the time of publication, more than 200 community hospitals, moderate-sized private hospitals, and tertiary care academic centers participated in ACS-NSQIP data collection and process improvement.9–13The ACS-NSQIP publishes an annual participant use data file with national deidentified data for research and quality improvement purposes. The 2005–2006 participant use data file includes data from 121 centers and more than 150,000 cases. We used these data to identify the incidence of and preoperative risk factors for AKI after general surgery. We also sought to create a risk index using these risk factors and to establish the mortality associated with the development of AKI after general surgery. We hypothesized that general surgery procedures would demonstrate an AKI risk factor model distinct from cardiac and vascular surgery procedures. Second, we hypothesized that the development of AKI after general surgery would be associated with an increased mortality independent of underlying comorbidities.
Materials and Methods
Patients and Data Collection
Institutional review board approval (University of Michigan Medical School, Ann Arbor, Michigan) was obtained for the data analysis of these prospectively collected data. Because no care interventions were mandated and no protected health information was collected or analyzed, signed patient consent was waived.
The ACS-NSQIP methodology has been described in detail elsewhere and is summarized here.10,12Operations necessitating general, epidural, or spinal anesthesia are prospectively divided into 8-day cycles. The first 40 general surgery and vascular surgery operations within each 8-day cycle are included. The 2005–2006 ACS-NSQIP participant use data file is a compilation of operations from 121 participating US medical centers submitted over a 1-yr period spanning 2005 and 2006. To maintain institutional, provider, and patient anonymity, no site- or region-specific data elements are included in the participant use data file. The following case types were excluded from the data analysis: procedures performed by the vascular, cardiac, urology, ophthalmology, podiatry, or obstetric services. If any concurrent cardiac, obstetric, or urologic procedures were performed, the case was excluded. Because of their low-acuity nature, outpatient procedures were excluded. Patients with preexisting acute renal failure (defined as rapid steadily increasing azotemia and serum creatinine ≥ 3.0 mg/dl within 24 h of surgery) or preexisting dialysis dependence were excluded.
For each operation, a trained risk assessment nurse prospectively collected preoperative patient demographics, preoperative comorbidities, operative information, selected intraoperative elements, and postoperative adverse occurrences up to 30 days after the operation. Detailed, standardized definitions of ACS-NSQIP preoperative patient demographics and comorbidities are available in appendix 1. High-risk procedures were defined as intraperitoneal procedures excluding hernia repairs.8Preoperative serum creatinine values were defined as the most recent serum creatinine (mg/dl) measured within 90 days of the surgery. Mild preoperative renal insufficiency was defined as a serum creatinine between 1.2 and 1.9 mg/dl, whereas moderate preoperative renal insufficiency was defined as a serum creatinine of 2.0 mg/dl or greater. Diabetes mellitus was evaluated as two separate clinical elements: (1) diabetes mellitus necessitating oral hypoglycemic therapy without insulin therapy and (2) diabetes mellitus necessitating insulin therapy with or without oral hypoglycemic therapy.3,14
Surgical nurse data collectors completed standardized and detailed training regarding the definitions of study variables. Regular conference calls, annual meetings, and site visits were used to maintain data reliability. Sites with interrater reliability audit scores demonstrating 5% or greater disagreement were excluded from the ACS-NSQIP participant use data file.
On the 30th postoperative day, the nurse obtained outcome information through chart review, reports from morbidity and mortality conferences, and communication with each patient by letter or by telephone. The primary outcome was AKI defined as either ACS-NSQIP renal morbidity outcome: progressive renal insufficiency or acute renal failure necessitating dialysis. Progressive renal insufficiency was defined as “the reduced capacity of the kidney to perform its function as evidenced by an increase in creatinine of > 2 mg/dl from preoperative value, but with no requirement for dialysis.” Acute renal failure necessitating dialysis is defined as “in a patient who did not require dialysis preoperatively, worsening of renal dysfunction postoperatively requiring hemodialysis, peritoneal dialysis, hemofiltration, hemodiafiltration, or ultrafiltration.” Two secondary outcomes were recorded: (1) 30-day all-cause mortality and (2) a composite non-AKI morbidity endpoint of pneumonia, pulmonary embolus, stroke, cardiac arrest, myocardial infarction, sepsis, or septic shock. Detailed definitions for these outcomes are listed in appendix 2.
Statistical analysis was performed using SPSS® versions 15 and 16 (SPSS Inc., Chicago, IL). Patients meeting inclusion criteria were randomly assigned to a derivation (75%) or validation (25%) cohort data set. The derivation cohort was used to build the AKI preoperative risk stratification model and score. The validation cohort was used to assess for internal validity as described by Harrell and as used by others.9,14,15First, descriptive statistics were performed on each preoperative variable to compare patients with and without postoperative AKI. All patient and operative characteristics were compared using the Mann–Whitney U test for continuous variables and the chi-square test for categorical variables.
Because of the large number of patients with a missing preoperative serum creatinine, we used the Missing Value Analysis module of SPSS version 16 to assess the impact of imputation on the model.16,17Collinearity diagnostics and Pearson correlations were evaluated for all preoperative predictors in this derivation cohort. To improve clinically usability, continuous variables were transformed into dichotomous variables by identifying the maximal sum of sensitivity and specificity. All remaining variables were entered into a logistic regression full model fit to identify significant independent predictors of AKI. All variables deemed to be significant in the full model fit (P < 0.05) were established as independent predictors. The resulting model's predictive value was evaluated using a receiver operating characteristic area under the curve, or c statistic.18Each variable was assessed for effect size using adjusted hazard ratios.19,20
An unweighted risk score assigning one point to each risk factor was created using the independent risk factors. In addition, a weighted risk score based on the β coefficient of the independent predictors was derived from the logistic regression model.21In the weighted score, the points assigned to each risk factor were derived by dividing each β coefficient by the smallest β coefficient of the independent predictors, multiplying by 2, and rounding to the nearest integer.21The unweighted and weighted scores were compared using the c statistic.18
The model was tested against the validation cohort via several mechanisms. First, both the unweighted and the weighted prediction scores were applied to the validation cohort, and a c statistic was calculated. In addition, the incidence of AKI among patients with similar preoperative risk scores was compared between the derivation and validation cohorts.
Finally, to compare the all-cause 30-day mortality and composite morbidity endpoints, we developed an AKI propensity score based on the logistic regression full model fit to control for coexisting comorbidities. The propensity score for each patient was the predicted probability (0 to 1) of developing AKI as defined by the output of the logistic regression model performed on the raw (nonimputed) derivation patient data set. AKI patients were matched using a five-digit manual matching algorithm to patients who did not experience AKI. If a five-digit match was not available, the patient was not used in the matched analysis. Mortality was compared using a Cox proportional hazards model that incorporated all AKI risk factors and the development of AKI itself as independent variables. The composite non-AKI morbidity endpoint was compared using a chi-square test.
A total of 152,244 distinct operations were detailed in the ACS-NSQIP participant use data file spanning a 1-yr period from 2005 to 2006. Thirty-day follow-up was achieved for all patients included in the data set. Of 75,952 operations that met the inclusion criteria for the study, 57,080 were randomly allocated to the derivation cohort and 18,872 were randomly allocated to the validation cohort. The majority of exclusions were for one of two reasons: excluded surgical specialties or outpatient surgery (fig. 1). A wide variety of general surgery procedures were represented in the final data set (table 1).
Of the 75,952 patients included the final analysis, 762 patients (1.0%) experienced the primary outcome of AKI. Of the 762 patients, 358 met the progressive renal insufficiency criteria and 460 met the acute renal failure criteria. Fifty-six patients were coded as meeting both criteria. In general, patients experiencing AKI were older, more likely to be male, and more likely to have a variety of comorbidities than were patients without AKI (table 2).
Data completion rates were excellent for all historic and demographic elements, with greater than 99.9% valid data. Preoperative serum creatinine was not available for 7,167 patients (9.4%). Patients missing a preoperative serum creatinine were more likely to be younger and healthier (data not shown) and less likely to experience AKI (0.6% vs. . 1.0%; P < 0.001). Of the 762 patients who experienced AKI, 40 (5.2%) had a missing preoperative serum creatinine value, whereas 7,127 (9.5%) of the 75,190 patients without AKI had a missing preoperative serum creatinine value (P < 0.001).
Missing value analysis demonstrated that the preoperative creatinine data were missing at random. The expectation-maximization algorithm with a tolerance of 0.001 and convergence of 0.0001 was used to impute missing preoperative creatinine values only.17The logistic regression full model fit was performed on both the raw and imputed derivation cohort data set (table 3).
Collinearity diagnostics demonstrated a condition index above 30, so the construction of a bivariate correlation matrix was necessary. No correlation issues were identified; therefore, no variables were removed. Age was transformed into a dichotomous variable; the maximal sum of sensitivity and specificity was 56 yr. Body mass index was not entered into the logistic regression model because it demonstrated a poor c statistic of 0.51 and the mean body mass index of the AKI and control groups were both 30 kg/m2(P = 0.73). All remaining variables listed in table 2were entered into a logistic regression full model fit with AKI as the dependent dichotomous variable.
The imputed data set logistic regression model included 57,075 patients (> 99.9%) and demonstrated that the independent predictors of AKI (P ≤ 0.05) were age 56 yr or older, male sex, emergency surgery, intraperitoneal surgery, diabetes mellitus necessitating oral hypoglycemic therapy, diabetes mellitus necessitating insulin therapy, active congestive heart failure, ascites, hypertension, mild preoperative renal insufficiency, and moderate preoperative renal insufficiency (table 3). The omnibus test of model coefficients demonstrated a chi-square value of 1,024.5 with 18 degrees of freedom and a P value less than 0.001. The c statistic of the model was 0.83 ± 0.01. The raw (nonimputed) data set logistic regression model included 49,929 patients (88%) and demonstrated excellent agreement with the imputed data set, with a c statistic of 0.83 ± 0.01. Adjusted hazard ratios are reported for each predictor (fig. 2and table 3). In the raw (nonimputed) data set logistic regression model, diabetes mellitus necessitating oral hypoglycemic therapy demonstrated borderline statistical significance at 0.058. However, because the adjusted hazard ratio was significant (1.3; 95% confidence interval, 1.0–1.7) and it was significant in the imputed model, it was retained in the weighted and unweighted prediction scores. All subsequent analyses and descriptive statistics were performed on the raw (nonimputed) data set (tables 4–6).
The unweighted and weighted prediction scores were based on the 11 independent predictors. Comparison of receiver operating characteristic curves demonstrated an area under the curve of 0.82 ± 0.01 for the weighted score and 0.81 ± 0.01 for the unweighted score. Unweighted scores ranged from 0 to 9 because the two severity classes for diabetes mellitus and preoperative renal insufficiency were each mutually exclusive. To improve clinical usability, we created five General Surgery AKI Risk Index classes: class I (zero, one, or two points), class II (three points), class III (four points), class IV (five points), and class V (six or more points). The classes were created by identifying groups of scores that resulted in “highly significant” (P < 0.001) differences in the incidence of AKI between consecutive classes (i.e. , class I vs. class II, class II vs. class III, etc. ). The incidence of AKI and hazard ratios increased with risk class and demonstrated consistency across the derivation and validation cohort (table 5). The c statistic for the General Surgery AKI Risk Index was 0.80 ± 0.01 (fig. 3) in the derivation cohort and 0.80 ± 0.02 in validation cohort (n = 18,872).
Propensity score matching based on the preoperative likelihood of developing AKI allowed the creation of two patient groups from the derivation cohort that were similar in terms of patient and operative characteristics (table 6). Each patient's propensity score was the predicted probability of AKI as derived in the logistic regression full model fit performed on the raw (nonimputed) data set. The predicted probability is based on the β coefficient for each risk factor in the full model.22A one-to-one five-digit match was achieved for 499 patients. All-cause 30-day mortality for the patients who developed AKI was 42%, whereas it was only 8.6% for their matched cohorts that did not develop AKI, correlating with a hazard ratio of 7.5 (95% confidence interval, 5.2–10.8). Cox proportional hazard analysis demonstrated that the development of AKI was a significant independent predictor of 30-day mortality (P < 0.001). The omnibus test of model coefficients demonstrated a chi-square value of 241.187, 12 degrees of freedom, and P < 0.001. The incidence of the composite morbidity endpoint for the patients who developed AKI was 66%, whereas it was only 19% for their matched cohorts who did not develop AKI, correlating with a hazard ratio of 8.3 (95% confidence interval, 6.2–11.2; P < 0.001; table 6).
We have reviewed the incidence, predictors, and mortality impact of AKI in a general surgery population using a large national clinical research data set. Our data demonstrate that AKI occurs in approximately 1% of patients undergoing general surgery procedures and that the development of AKI was associated with an eightfold increase in all-cause 30-day mortality. Furthermore, we have developed an effective preoperative risk prediction model that can be used for patient education, postoperative observation, and patient selection for prospective studies.
Our findings shed light on a clinical problem with limited existing literature. Approximately 1–5% of hospitalized patients experience AKI.23–25Previous studies on AKI among hospitalized patients have been limited by the inclusion of very heterogenous patient populations, poorly defined reasons for admission, variant surgical types, and administrative data sources for concomitant disease information. There are no current data on the incidence, predictors, or impact of AKI after general surgery. Using single-center data, we have previously demonstrated that 0.8% of patients with previously normal renal function undergoing noncardiac surgery would experience AKI defined as a postoperative estimated creatinine clearance less than 50 ml/min.8These data, however, included patients undergoing high-risk vascular surgery procedures and focused on patients without preexisting renal insufficiency.
The cardiac surgery literature has extensively evaluated AKI, demonstrating that between 1% and 15% of patients exposed to cardiopulmonary bypass will experience a marked increase in serum creatinine, with 2% requiring renal replacement therapy.1–4,6,26–28However, these data also have questionable applicability to general surgery patients given the unique pathophysiology associated with cardiopulmonary bypass.4,29Similarly, the vascular surgery literature demonstrates rates of renal dysfunction of approximately 5% with less than 1% of patients requiring renal replacement therapy.30Because of the marked alterations in renal blood flow induced by suprarenal or infrarenal aortic cross-clamping, it is unlikely that general surgery patients experiencing AKI are subjected to similar physiologic derangements.
Our data demonstrate a 1% incidence of AKI in a broad general surgery population across the United States. Facilities contributing data to the ACS-NSQIP participant use data file include tertiary care academic centers, moderate-sized private hospitals, and community hospitals. In addition, because we are not using an administrative data set, the patients are not limited to Medicare beneficiaries and the concomitant skewing of age distribution.25The resulting broad array of patients and medical centers involved in the ACS-NSQIP offers a truly representative sample. The inclusion of nearly 76,000 patients makes this analysis the most comprehensive to date as well. For these reasons, the data serve as the first definitive literature establishing the incidence of AKI after general surgery in the United States. They serve as a foundation for a more informed patient consenting process. In addition, they establish postoperative AKI as a complication not limited to high-risk cardiovascular procedures. The 1% incidence rivals that of other feared perioperative complications, such as cardiac adverse events9or venous thromboembolism,31but AKI after general surgery has not been the focus of risk reduction strategies.32
The General Surgery AKI Risk Index demonstrates an excellent predictive capability, with a c statistic of 0.80. The Risk Index is easy to calculate and can be readily incorporated into clinical practice because it is based on commonly acquired history, physical, and laboratory data elements. It has a predictive value superior to other landmark cardiovascular outcome prediction models such as the Lee Revised Cardiac Risk Index for perioperative cardiac events (c statistic = 0.76) and the Preoperative Renal Risk Stratification for cardiac surgery (c statistic = 0.76) of Chertow et al. 6,14In addition, the General Surgery AKI Risk Index demonstrated excellent consistency in the validation cohort (c statistic = 0.80), providing internal validity to the analysis (table 5).
Several of the AKI predictors in this study have also been identified for patients undergoing cardiovascular surgery: advanced age, diabetes mellitus, active congestive heart failure, hypertension necessitating medication, preexisting renal dysfunction, and emergent surgery.1–4,6,27,28,33We have also confirmed intraperitoneal surgery as an independent predictor of AKI, consistent with previously published general surgery data.8We have identified, for the first time, that the presence of ascites is an independent risk factor for AKI after general surgery. Existing literature indicates that preoperative liver dysfunction and jaundice predispose a patient to AKI.8,34–37It is not immediately clear from the available data why ascites itself may predispose to AKI after general surgery. It is possible that other mechanisms related to fluid shifts or common therapies for ascites (e.g. , diuretics) may be involved in predisposing these patients to postoperative AKI. These hypotheses will necessitate further investigation and a more detailed data set.
Previous cardiac surgery literature has suggested that sex either plays no role in AKI or that female sex confers independent risk.3,6,28However, our data suggest that male sex doubles the risk of AKI after general surgery. Unfortunately, few of the risk factors we have identified can be easily corrected before an operation. However, clinicians may be able to optimize ascites and congestive heart failure. The use of general anesthesia was not associated with AKI, but we are reticent to draw conclusions from these data given that few patients in the derivation cohort underwent regional or neuraxial techniques (378 patients, 0.6%). Many of the risk factors associated (P < 0.05) with AKI in the univariate analysis (table 2) were not found to be independent predictors in the multivariate logistic regression full model fit: chronic obstructive pulmonary disease, recent myocardial infarction, previous cardiac intervention, peripheral vascular occlusive disease, cerebrovascular disease, and long-term steroid use.
Our data and the resulting AKI risk index are an important first step toward identifying strategies to reduce the incidence of AKI after general surgery. Historically, most trials of therapeutics (diuretics, intravenous hydration, n-acetylcysteine, etc. ) purported to prevent AKI have focused on high-risk vascular procedures because these prospective trials require high events rates to be sufficiently powered.4,38Our data offer the ability to identify high-risk patients and develop prospective, randomized risk reduction trials focused on the patients most likely to experience AKI.
Our data also demonstrate that the development of AKI is independently associated with 30-day all-cause mortality. This is consistent with previous single-center data for general surgery patients8and larger data sets for cardiac surgery patients.5,28Our observed mortality association is independent of underlying comorbidities that may be associated with mortality. However, because of the observational nature of the study, we cannot comment on causality.
There are several limitations to our study. First, the observational nature of the study did not enable specific detailed data collection on patients exhibiting the outcome. Therefore, our ability to provide additional descriptive information regarding this important group of patients is limited. In addition, because the data were collected as part of a large prospective observational study, some data elements pertinent to AKI pathophysiology were not collected and cannot be retrospectively acquired. These include preoperative and intraoperative hydration, use of nephrotoxic agents, use of specific volatile agents associated with perioperative renal dysfunction, and postoperative medical management. Next, the ACS-NSQIP participant use data file lacks any regional or facility specific information. As a result, we are not able to comment on specific practice patterns or regional factors and their impact on the risk of AKI. In addition, although we chose to define preexisting renal dysfunction on the basis of serum creatinine, some may argue that estimated creatinine clearance may be a better predictor of outcome.1In addition, we lacked preoperative serum creatinine data for approximately 9% of patients in the data set. Finally, although this data set uses rigorous and validated definitions, these definitions could not be adjusted for the purposes of this specific study.
In summary, these data are of interest to patients, surgeons, anesthesiologists, nephrologists, and intensivists alike as they attempt to decrease the risk of AKI after general surgery. We have established an incidence of 1% and an eightfold increase in mortality independent of underlying comorbidities. We have derived a General Surgery AKI Risk Index that demonstrates excellent discriminating capability. These data can be used to target populations for prospective trials attempting to reduce the risk of this devastating complication.